初次全膝关节置换术中环周电灼去神经支配髌骨:一项随机对照试验
该单中心双盲随机对照试验纳入142例40岁以上、接受不置换髌骨的全膝关节置换术患者,比较环周电灼去神经支配与不去神经支配的疗效。术后1年牛津膝关节评分组间无差异(平均差1.87,95%CI -1.28至5.03),Bartlett髌骨评分和12项简短健康调查也无差异;WOMAC虽达统计学显著差异但低于最小临床重要差异。结论为无临床相关获益,不推荐用于临床实践。
要点
- 术后1年牛津膝关节评分环周电灼去神经支配组与不去神经支配组无差异(平均差1.87,95%CI -1.28至5.03)。
- Bartlett髌骨评分(平均差0.490,95%CI -1.61至2.59)和12项简短健康调查(平均差0.196,95%CI -2.54至2.93)均无差异。
- WOMAC差异有统计学意义但低于最小临床重要差异(平均差4.79,95%CI 1.05至8.52),作者不推荐该治疗用于临床实践。
核心结论
- 在不置换髌骨的全膝关节置换术患者中,环周电灼去神经支配未检测到临床相关获益,包括膝前痛方面也无获益,因此不推荐用于临床实践。
研究设计与样本
- 单中心双盲随机对照试验,纳入142例40岁及以上、接受不置换髌骨(常规治疗)的全膝关节置换术患者,其中49例(35%)分配至去神经支配干预组。
- 采用随机生成的治疗分配序列,置于编号、密封、不透明信封中;参与者对治疗分配设盲,无交叉。
- 主要结局为术后1年牛津膝关节评分;次要结局为Bartlett髌骨评分、WOMAC和12项简短健康调查;采用线性回归分析校正年龄、性别和基线(术前)评分。
- 因随机化方法导致早期治疗分配率不平衡,中期统计分析确认两组数量充足后提前停止招募。
- 患者平均年龄71岁(范围50至85岁),51%(n=74)为女性。
主要发现
- 术后1年牛津膝关节评分未检测到差异(平均差1.87;95%CI -1.28至5.03)。
- Bartlett髌骨评分未检测到差异(平均差0.490;95%CI -1.61至2.59)。
- 12项简短健康调查未检测到差异(平均差0.196;95%CI -2.54至2.93)。
- WOMAC检测到统计学显著差异,但低于WOMAC的最小临床重要差异(平均差4.79;95%CI 1.05至8.52)。
关键数值与推荐
- 主要结局牛津膝关节评分平均差1.87(95%CI -1.28至5.03),未达统计学显著。
- Bartlett髌骨评分平均差0.490(95%CI -1.61至2.59),未达统计学显著。
- 12项简短健康调查平均差0.196(95%CI -2.54至2.93),未达统计学显著。
- WOMAC平均差4.79(95%CI 1.05至8.52),达统计学显著但低于最小临床重要差异。
- 证据等级为Level 1。
临床怎么用
- 作者结论为不推荐将髌骨环周电灼去神经支配用于不置换髌骨的全膝关节置换术临床实践。
局限性
- 因随机化方法导致早期治疗分配率不平衡,中期统计分析确认两组数量充足后提前停止招募。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to investigate the clinical effectiveness of patella rim electrocautery "denervation" versus no denervation in patients undergoing total knee arthroplasty (TKA). METHODS: We conducted a single-center, double-blind randomized controlled trial. Patients aged 40 years or older, due to undergo a TKA who did not have patella resurfacing (usual care) were randomized with or without circumferential patella electrocautery. This was undertaken according to a randomly generated sequence of treatment allocation that was placed into numbered, sealed opaque envelopes. Participants were blinded to treatment allocation. There was no crossover. The primary outcome was Oxford Knee Score at 1 year postoperatively. Secondary outcomes were Bartlett Patella Score, Western Ontario and McMaster Universities Arthritis Index (WOMAC), and 12-Item Short Form Survey. Linear regression analyses were performed with adjustments by age, sex, and baseline (preoperative) scores. There were 142 participants recruited, of which 49 (35%) were allocated to the denervation intervention. Recruitment was stopped early when interim statistical analyses confirmed adequate numbers in both groups despite an imbalance in early treatment allocation rates due to the randomization method. The mean patient age was 71 years (range, 50 to 85) and 51% (n = 74) were women. RESULTS: No difference in Oxford Knee Score was detected at 1 year (mean difference [MD] 1.87; 95% confidence interval [CI] -1.28 to 5.03). No difference was detected in Bartlett Patella Score (MD 0.490; 95% CI -1.61 to 2.59) or 12-Item Short Form Survey (MD 0.196; 95% CI -2.54 to 2.93). A statistically significant difference in WOMAC was detected, but at a level less than the minimal clinically important difference for WOMAC (MD 4.79; 95% CI 1.05 to 8.52). CONCLUSION: No clinically relevant benefit was detected from patella rim electrocautery in patients undergoing TKA who did not have patella resurfacing (including no benefit in terms of anterior knee pain). This treatment is therefore not recommended for clinical practice. LEVEL OF EVIDENCE: Level 1.
引用
- Spencer SJ, Jamal B, Abram SGF, et al. Patella Denervation With Circumferential Electrocautery in Primary Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2023. PMID: 36858129. doi:10.1016/j.arth.2023.02.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。